01 1Innopharmax
01 1SAPROPTERIN DIHYDROCHLORIDE
01 1Taiwan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-06-23
Pay. Date : 2019-03-22
DMF Number : 33553
Submission : 2019-02-19
Status : Active
Type : II
20
Innopharmax Inc, based in Taiwan, is a pharmaceutical company.
One of their notable products is SAPROPTERIN DIHYDROCHLORIDE, with a corresponding US DMF Number 33553.
Remarkably, this DMF maintains an Active status since its submission on February 19, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 23, 2020, and payment made on March 22, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
